Published on 6 Oct 2023 on Simply Wall St. via Yahoo Finance
Enzo Biochem (NYSE:ENZ) shareholders have endured a 63% loss from investing in the stock five years...
Generally speaking long term investing is the way to go. But unfortunately, some companies simply don't succeed. For example the Enzo Biochem, Inc. (NYSE:ENZ) share price dropped 63% over five years. That is extremely sub-optimal, to say the least. And some of the more recent buyers are probably worried, too, with the stock falling 38% in the last year. Furthermore, it's down 23% in about a quarter. That's not much fun for holders.
So let's have a look and see if the longer term performance of the company has been in line with the underlying business' progress.
Check out our latest analysis for Enzo Biochem